...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung disease.
【24h】

The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung disease.

机译:心脏外科手术前使用肺活量测定法可能会影响胸外科医师学会的风险预测评分:这是一项对一组慢性肺病高风险患者进行的前瞻性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Chronic lung disease is a significant comorbidity in patients undergoing cardiac surgery. Chronic lung disease is currently being classified and reported to the Society of Thoracic Surgeons database by using either clinical interview or spirometric testing. We sought to compare the chronic lung disease classification captured by the 2 methods. METHODS: We performed a prospectively designed study in which patients presenting for cardiac surgery, excluding emergent patients, were screened for a history of asthma, a history of 10 or more pack-years of smoking, a persistent cough, and the use of oxygen. Each selected patient underwent spirometry. The presence and severity of chronic lung disease was coded per Society of Thoracic Surgeons guidelines by using the 2 methods of clinical report and spirometric results. The chronic lung disease classifications were compared, and differences were determined by using concordance and discordance rates. The results were then used to construct Society of Thoracic Surgeons-predicted risk models. RESULTS: The discordant rate was 39.1%, with underestimation of the severity of chronic lung disease in 94% of misclassified patients. This affected the Society of Thoracic Surgeons-predicted risk models for prolonged ventilation, morbidity/mortality, and mortality by increasing the predicted risk when spirometry was used for morbidity/mortality by an average of 1.5 +/- 1.2 percentage points (P < .001) and prolonged ventilation time by an average of 1.3 +/- 1.4 percentage points (P < .001). CONCLUSION: The use of patient history for symptoms, medication, and/or oxygen use as the only method to determine chronic lung disease for this subgroup of patients led to underreporting of chronic lung disease and underestimation of the risk for adverse outcomes. Therefore data submission to the Society of Thoracic Surgeons database should be designed to capture and correct for potential bias in the definition of chronic lung disease because the rate of spirometry in different centers in defining chronic lung disease is not regulated.
机译:目的:慢性肺病是心脏手术患者的重大合并症。目前正在对慢性肺疾病进行分类,并通过临床访谈或肺活量测试向胸外科医师协会数据库报告。我们试图比较两种方法捕获的慢性肺疾病分类。方法:我们进行了一项前瞻性设计研究,在该研究中,对进行心脏外科手术的患者(不包括急诊患者)进行了哮喘病史,10年或更多包年吸烟史,持续咳嗽和吸氧的检查。每个选定的患者都要进行肺活量测定。慢性肺病的存在和严重程度是根据《胸外科医师学会指南》使用临床报告和肺活量测定结果的两种方法进行编码的。比较慢性肺疾病的分类,并通过一致性和不一致率确定差异。然后将结果用于构建胸外科医师协会预测的风险模型。结果:不合格率为39.1%,低估了94%误分类患者的慢性肺病严重程度。当将肺活量测定法用于发病率/死亡率的预测风险增加平均1.5 +/- 1.2个百分点时,这会影响胸外科医生协会预测的长期通气,发病率/死亡率和死亡率的风险模型(P <.001 ),平均延长通风时间1.3 +/- 1.4个百分点(P <.001)。结论:利用患者的病史,症状,用药和/或吸氧作为确定该亚组患者慢性肺病的唯一方法,导致对慢性肺病的报告不足,并低估了不良结局的风险。因此,应设计向胸外科医师协会数据库提交的数据,以捕获和纠正慢性肺病定义中的潜在偏倚,因为在定义慢性肺病的不同中心,肺活量测定的速率没有受到监管。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号